Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ3 | O43525 | 10/20 | 0.40 |
| ▸ | KCNQ2 | O43526 | 10/20 | 0.40 |
| ▸ | KCNE1 | P15382 | 8/20 | 0.38 |
| ▸ | KCNQ1 | P51787 | 8/20 | 0.38 |
| ▸ | MALT1 | Q9UDY8 | 4/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3712710 | 0.92 | CNR1 (0.43) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3698652 | 0.92 | NTRK1 (0.39) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3702068 | 0.91 | KCNQ3 (0.39) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3698170 | 0.91 | MALT1 (0.38) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3694760 | 0.89 | MALT1 (0.39) | KCNQ3KCNQ2MALT1NFKB1NFKB2 | |
| SCHEMBL3694274 | 0.85 | NTRK1 (0.36) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3691798 | 0.85 | KCNQ3 (0.37) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3694337 | 0.85 | MALT1 (0.35) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3694848 | 0.85 | SCN9A (0.41) | KCNQ3KCNQ2KCNE1KCNQ1MALT1 | |
| SCHEMBL3692782 | 0.84 | THRB (0.38) | KCNQ3KCNQ2KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2190822-B1 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2014-12-31 | — | — | EP | disclosed |
| EP-2190822-A2 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009041705-A9 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2009-08-13 | — | — | WO | disclosed |
| US-20090156642-A1 | 5-Membered heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-18 | — | — | US | disclosed |
| WO-2009041705-A2 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156642-A1 | 5-Membered heterocyclic compound | CEL, PGA5, COG5 | KCNQ3 4287/4885KCNQ2 3933/4885KCNE1 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.